|
|
|
|
Science Sparks @ ACTREC
|
 28thApril 2025 |
Vol. No. 14 ; Issue No.680 |
|
|
Publications
|
|
1. Dahara R, Bhattacharyya D (2025). Intra-Golgi Golgin PpSgm1 and GRIP domain Golgin PpImh1 synergistically mediate Golgi cisternal stacking. Journal of Cell Science.
2. Rai P, Janu AK, Shetty N, Kulkarni S (2025). Current landscape of Short-T2 imaging techniques in the musculoskeletal system: The past, present and future. Journal of Magnetic Resonance Imaging.
3. Shankar MSR, Neeraja M, Chowdhry M, Yadav A, Machiraju S, Singh M, Gowrishanker S (2025). "Virtual crossmatch reveals donor-specific MICA antibodies in antibody mediated rejection: First established Indian case". Transplant Immunology.
4. Ramani N, Patwardhan RS, Checker R, Singh B, Morjaria S, Kumar BK, Gurjar M, Gota V, Sharma D (2025). Preclinical evaluation of sodium copper chlorophyllin: safety, pharmacokinetics, and therapeutic potential in breast cancer chemotherapy and cyclophosphamide-induced bladder toxicity. Naunyn-Schmiedeberg's Archives of Pharmacology
|
|
|
|
|
|
|
Video of the Week
|
|
| Learning conventional breast radiotherapy planning from indication to implementation |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1979, Researcher found the first cancer causing gene, an oncogene in human bladder cancer.
|
|
|
|
Cancer News
|
| |
|
Tata Memorial Centre launches ‘MenCan’ initiative to address rising burden of male cancers in India
|
|
Press Information Bureau, 24/04/2025
|
|
In a significant step towards advancing cancer care for men in India, the Tata Memorial Centre (TMC) has officially launched MenCan, a dedicated initiative by the Urologic Oncology Disease Management Group (URO DMG)...
|
| |
|
Researchers in Nashik develop blood test to detect 30 different types of cancer
|
|
Biospectrum, 24/04/2025
|
|
The trial included 6,445 participants, with over 2,800 confirmed, treatment-naïve cancer patients across four stages of the disease. Remarkably, the platform showed consistent high sensitivity even in early-stage (Stage I/II) cancers, a feat rarely achieved by current diagnostic standards...
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
